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aging, disease, stress, ultraviolet radiation, exercise, cancer,
smoking, atherosclerosis, and chronic in?ammation. Studies
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butylated hydroxytoluene (BHT) and butylated hydroxyani

Ser. No. 12/088,156 ?led on Mar. 26, 2008 (issued as US.
Pat. No. 7,964,223), which in turn is a national stage appli
cation of international patent appl. no. PCT/U S06/ 37237 ?led
on Sep. 26, 2006 and claiming the bene?t of priority in US.
Provisional PatentAppl. Ser. No. 60/720,892 ?led on Sep. 27,
2005, the disclosures of each of which are incorporated in

sole (BHA) (Wang et al., 1997; Rice-Evans et al., 1995; Liu et

al., 2002; Proteggente et al., 2002; Wang et al., 1999).
In?ammation, or the biological state of being in?amed, is

generally characterized by pain, redness, and swelling, and
may result from physical causes such as injury, chemical
causes such as exogenous substances including toxins, or
biological causes such as infection by a virus, a bacteria, a

their entirety herein by reference.

parasite, or other disease-causing agent. As examples, various
conditions associated with in?ammation of the gastrointesti

TECHNICAL FIELD

nal tract are known, including but not limited to acute or
chronic conditions or diseases such as in?ammatory bowel

The present invention relates to compositions having anti
oxidant and anti-in?ammatory activity, derived from a berry.

disease, gastroesophageal re?ux disease, diarrhea, radiation
induced enteritis, chemotherapy-induced enteritis, Crohn’s
disease, irritable bowel syndrome, diverticulitis, ulcers, coli
tis, viral infection, bacterial infection, and parasitic infection

In particular, the invention relates to a method for deriving an

extract having antioxidant and anti-in?ammatory activity
from a berry, and to formulated compositions derived by the
method for oral and topical administration. Still further, the
invention provides methods and compositions for treatment
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or infestation. In individuals a?Iicted with the above and

similar conditions, affected cells such as dendritic cells,

monocytes, macrophages, ?broblasts, endothelial cells, and T

of in?ammation, oxidative stress, or cancer comprising
administering an effective amount of the composition of the
invention.
25

BACKGROUND OF THE INVENTION

cells release causative agents, including cytokines such as
interleukins (IL), tumor necrosis factor (TNF), interferons
(IFN), and the like which trigger in?ammation and/or an

in?ammatory response. Cytokines important in in?ammation
include, but are not limited to, IL-1, IL-6, IL-12, TNF-(x, and

Polyphenolics (also known as phenolics) are metabolites
found in plants, fruits, and vegetables. Phenolics have a num
ber of functions including acting as free radical scavengers.
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Thus, phenolics disrupt many biological processes. The most
notable type of phenolics are ?avonoids which consist of

proanthocyanidins, anthocyanidins, ?avones, ?avonols and
their glycosides (Macheix, 1990). Anthocyanins are respon

processes.
Anti-cancer property, effect, or activity refers to a property
of a substance, chemical, or material that can slow the prolif

eration of tumor cells (termed anti-proliferative effect), or kill
tumor cells (termed cytotoxic effect). Recent studies have

sible for the red, purple, and blue colors of many fruits and
vegetables. The term anthocyanin refers to a group of pig
ments found in plants, fruits, and vegetables that can be
classi?ed as both ?avonoid and phenolic. Anthocyanins are
not found in animals, microorganisms, or marine plants. It is
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thought that anthocyanins function by attracting insects to

40

shown also that berries such as black raspberries possess

cancer-preventing properties at both in-vitro and in-vivo lev
els (Kresty et al., 2001; Castro et al., 2002; Xue et al., 2001;
Huang et al., 2002; Rodrigo et al, in press; US. patent appli
cation Ser. No. 10/951,413). In particular, anthocyanins have

promote pollination but also to protect the plants from dam
age caused by ultraviolet (UV) radiation. Anthocyanins are

been shown to demonstrate a wealth of chemopreventive

properties (Hecht et al., in press; Liu et al., 2002; Katsube et

al., 2003; Hu et al., 2003).
However, anthocyanin compounds are inherently unstable

glycosides of polyhydroxyl and polymethoxyl derivatives of
2-phenylbenzopyrylium or ?avylium salts, and are soluble in
water. The anthocyanins are electron de?cient, and are there

IFN-(x. Anti-in?ammatory properties, effects, or activity
refers to reducing in?ammation and promoting healing of
cells and tissues subject to in?ammation and/or in?ammatory
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both in vivo and in vitro, and tend to degrade over time,
negating any health or medical bene?ts associated therewith

fore are strong scavengers for reactive oxygen species (ROS)

(Rubinskiene et al., 2005; Nielsen et al., 2003; Morais et al.,

such as free radicals. Although there are hundreds of different

2002). A need in the art therefore exists for methods for

anthocyanins found in nature, six anthocyanin compounds

preparing compositions from anthocyanin-containing fruits

predominate including: delphinidin, petunidin, cyanidin, pel

such as berries which provide a stable anthocyanin content.

argonidin, peonidin, and malvidin. The daily intake of antho
cyanins in the United States is about 180-215 mg/day, and
constitute the largest intake of phenolic compounds (Hertog,
1 993).
Anthocyanins originally drew interest due to their role in
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color degradation in fruits, and their potential use as natural
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food colorants. More recently, anthocyanins have received

administration are described herein. However, it will be
appreciated that other formulations are contemplated and can

be derived by the skilled artisan from the teachings herein
using methods known in the art, including injectable formu
lations. Accordingly, the present invention contemplates also
injectable formulations including, but not limited to, solu

attention because of their possible health bene?ts as natural

antioxidant and anti-in?ammatory compounds, and poten
tially as anti-cancer compounds. Antioxidant property,
effects, or activity refers to compositions that inhibit, reduce,

Still further, there is a need for compositions including such
stable anthocyanin compositions to provide health and medi
cal bene?ts to individuals utiliZing them. In particular, com
positions formulated for oral administration and topical
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tions, suspensions, emulsion, microemulsions, micelles, lipo

or reverse oxidation or the effects of oxidation, such as for

somes, nanoparticles, microparticles, implants, depots, and

example the oxidative process caused by free radicals. A free

polymer conjugates.

radical may be any chemical species that includes one or more

unpaired electrons, and without limitations includes chemi
cals such as hydroxyl radical, superoxide radical, nitric oxide,
and nitrogen dioxide. Examples of conditions involving free
radical oxidative damage include, but are not limited to,

SUMMARY OF THE INVENTION
65

The present invention provides methods for deriving stable

compositions from blackberries, and compositions incorpo
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rating such stable compositions. In one aspect, a method is

FIG. 1 shows percent weight increase of active blackberry

provided for preparing a composition having antioxidant and
anti-in?ammatory activity, comprising exposing a berry to a

powder as a function of time when stored at 25° C. and at 4°

C.;

solvent composition having a pH of from about 1 to about 3,
adding a cryoprotectant, and recovering a berry extract hav
ing a stable anthocyanin content. The berry may be a black
berry. In one embodiment, the method comprises the steps of

FIG. 2 depicts a standard HPLC chromatogram of a black

berry extract made according to the present invention;
FIGS. 3A and 3B show the stability of anthocyanins as a

function of pH and time;
FIG. 4 shows the stability of a speci?c anthocyanin (cya
nidin-3-glucoside) in a blackberry preparation made accord

physically disrupting a quantity of berries, exposing the
physically disrupted berries to the solvent composition,
recovering a berry extract having a pH of from about 1.0 to
about 4.5, and adding a cryoprotectant. The cryoprotectant is
added in an amount of at least 2: 1 (w/w) cryoprotectantzberry
extract. The berry extract so provided typically comprises at

blackberry preparations made according to the present inven

least one stable anthocyanin in an amount effective to provide

tion as a function of time and temperature;

ing to the present invention as a function of time and storage

condition;
FIGS. 5A and 5B show the stability of anthocyanins in

antioxidant and anti-in?ammatory activity. In another

FIG. 6 presents a dissolution pro?le of enteric-coated hard

embodiment, the recovered berry extract has a pH of about

capsules containing a berry composition according to the

3.5. The physically disrupted berries may be dewatered prior
to being exposed to the solvent composition, after being

present invention;

exposed to the solvent composition, or both.

capsules containing a berry extract according to the present

In another aspect, the present invention provides stabilized

FIG. 7 shows a dissolution pro?le of enteric-coated hard
20

invention;
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FIG. 8 shows inhibition of proliferation of HT-29 cells by
a blackberry extract according to the present invention; and
FIG. 9 shows inhibition of IL-12 release from murine den
dritic cells by a blackberry extract according to the present
invention.

compositions having antioxidant and anti-in?ammatory
activity, prepared by the method of the invention as described
above. In one embodiment, a composition is provided having
antioxidant and anti-in?ammatory activity, comprising a
berry extract having at least one stable anthocyanin in an
amount effective to provide antioxidant and anti-in?amma

Reference will now be made in detail to the present pre

tory activity. The berry extract is provided by the steps of
physically disrupting a quantity of berries and exposing the
physically disrupted berries to a solvent composition having
a pH of from about 1 to about 3, and adding a cryoprotectant,
which stabilizes the at least one anthocyanin. The cryopro
tectant is added in an amount of at least 2:1 (w/w) cryopro
tectant:berry extract. The berry extract may be derived from a

ferred embodiment of the invention, an example of which is

illustrated in the accompanying drawings.
30

Blackberries and raspberries, sometimes referred to as
“brambles”, are a species of fruit in the genus Rubus. Rubus is

quite diverse and has 12 subgenera with several of the sub

blackberry. Compositions comprising the berry extract of the
present invention, formulated for oral and/ or topical admin

DETAILED DESCRIPTION OF THE INVENTION
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genera having more than a hundred species. In the United

istration, are provided also, including without limitation

States, R. allegheniensis, R. argulus, R. cuneifolius, R.

nutritional supplements, capsules, tablets, chewing gum,

Canadensis, and R. lrivialis are the dominant Rubus species.

lotions, creams, mucoadhesive gels, vanishing lotions, van
ishing creams, and the like.
In yet another aspect, the present invention provides methods

Blackberries belong to the subgenus Eubalus, and have much
greater complexity than raspberries in terms of genetic back
40

ground, growth characteristics, and number of species.
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Blackberries are native to Asia, Europe, North and South
America. They have been grown in Europe for over 2000
years as food and for medical applications. Blackberries grow
in three different forms: trailing, semi-erect, and erect. In the
eastern half of the United States, the dominate form is the

for treatment of in?ammation, oxidative stress, or cancer in a

mammal in need thereof, comprising administering an effec
tive amount of the composition of the invention. Still yet
further, another aspect of the invention is compositions com
prising a therapeutically effective amount of the composition
of the invention, formulated in a pharmaceutically acceptable
vehicle. The composition may be provided in combination
with additional anticancer agents, additional anti-oxidant
agents, and/ or additional anti-in?ammatory agents.
As should be appreciated, the embodiments shown and

erect including the thorny types, Cherokee, Comanche, Chey
enne, Darrow, Illini Hardy Blackberry, Shawnee, and Choc
taw. The thornless cultivars include Hull, Chester, Navaho,
and Arapaho. Other types of blackberries include, but are not
50

limited to, Eldorado, Ebony King, Raven, Ranger, Hedrick,

described herein are an illustration of one of the modes best

Bailey, and Brazos. Semi-erect blackberries requiring a trellis

suited to carry out the invention. It will be realized that the

for production include Black Satin, Chester, Dirksen, Hull

invention is capable of other different embodiments and its
several details are capable of modi?cation in various, obvious
aspects all without departing from the invention. Accord

west, blackberries are often called Marionberries. Other ber

Thornless, Smoothstem, and Thornfree. In the Paci?c North
55

ries that have genetic similarity to blackberries include Boy

ingly, the drawings and descriptions will be regarded as illus

senberry, Loganberry, Olallieberry, and Youngberry. A 2002

trative in nature, and not as restrictive. Unless otherwise

report by the USDA lists the total US production of all black
berry types to be about 56 million pounds grown on 8370

indicated, all patents, patent applications, and non-patent
documents referenced in the present disclosure are incorpo

rated herein by reference in their entirety.
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BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings incorporated in and forming
a part of the speci?cation, illustrate several aspects of the
present invention and together with the description serve to

explain the principles of the invention. In the drawings:

acres. According to the USDA, of the blackberries harvested
in the US, about 40% are used for jams and jellies, 25% for
bakery products, 23% frozen or canned, and the 12% for
juices or other food.
Tsao et al. (2003) showed that, relative to other fruits,

blackberries have high concentrations of polyphenolics such
65

as anthocyanins with as much as 1923 ug/ g wet fruit. Sellap
pan et al. (2002) showed that blackberries had high concen

trations of ellagic acid; Chocktaw had 33.81 mg/ 100 g berry

US 8,367,126 B2
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and Kiowa had 30.01 mg/ 100 g berry. Blackberries were also
found to contain ?avonoids, with the major ?avonoid, cat

desired pH for the solvent composition, including, but not
limited, to hydrochloric acid, acetic acid, citric acid, lactic

echin, present in Choctaw at 312.86 mg/ 100 g berry. Sellap
pan showed that the average total anthocyanin and polyphe

acid, tri?uoroacetic acid, aspartic acid, glutamic acid, sulfur

nolic content in blackberries was 116591858 mg/100 g

maleic acid, and mixtures thereof. In yet another embodi

berry and 4865319713 mg/ 100 g berry, respectively.

ment, the alcohol can be replaced with a suitable ketone or a

containing acids such as sulfonic acid, phosphoric acid,

Accordingly, in one embodiment the present invention

suitable halogenated ole?n, such as acetone, chloroform,
methylene chloride, or mixtures thereof.
The physically disrupted berries may be dewatered to a
residual water content of up to 20% (w/v) prior to being

describes methods for deriving stable compositions from
blackberries, and compositions made by those methods.
However, it will easily be understood by those skilled in the
art that the methods and compositions taught in this invention
apply to many other types of fruits, plants, and vegetables
having an anthocyanin content, including but not limited to:

exposed to the solvent composition, after being exposed to the
solvent composition, or both. In one embodiment, the physi
cally disrupted berries are dewatered to a residual water con

strawberries, black raspberries, apple, crabapple, chokeberry,
Hawthorn, Juneberry, Loquat, pear, apricot, cherry, plum,
peach, various other raspberries, cloudbeny, wineberry,
salmonberry, bearberry, bilberry, cranberry, huckleberry, bar
berry, currant, elderberry, gooseberry, hackberry, honey

tent of up to 10% (w/v). It will be appreciated that any suitable
method may be employed for dewatering, such as heating or
centrifuging a berry puree to remove water, followed by
crushing the dried berry puree to a powder. Typically, a pow

der in accordance with the present invention is prepared by

suckle, nannyberry, sheepberry, sea grape, wolfberry, crow

beny, goumi, kiwi, various other grapes, thimbleberry,

20

salmonberry, various types of melons such as watermelon,

?g, lime, avocado, feijoa, guava, kumquat, longan, lychee,
passion fruit, and pineapple.

powder.

In one aspect, the present invention provides a method for

preparing a composition having antioxidant and anti-in?am
matory activity, comprising exposing a berry to a solvent
composition having a pH of from about 1 to about 3, adding

lyophilization or freeze-drying, i.e., freezing followed by
removal of water by sublimation. Bene?cially, freeze-drying
provides a chemically and physically stable, free-?owing dry

25

In another aspect, the present invention provides composi
tions having antioxidant and anti-in?ammatory activity, pre
pared by the method of the invention as described above. In
one embodiment, a composition is provided having antioxi

a cryoprotectant, and recovering a berry extract having a

dant and anti-in?ammatory activity, comprising a berry

stabilized anthocyanin content. As discussed above, the berry

extract having at least one stabilized anthocyanin in an
amount effective to provide antioxidant and anti-in?amma

may be a blackberry. In one embodiment, the method com

30

prises the steps of: physically disrupting a quantity of berries,
exposing the physically disrupted berries to the solvent com

tory activity. The berry extract may be provided by the steps
of physically disrupting a quantity of berries, exposing the

position, recovering a berry extract having a pH of from about
1.0 to about 4.5, and adding a cryoprotectant. Suitable cryo

physically disrupted berries to a solvent composition, and
adding a cryoprotectant, which stabilizes the at least one

such as glucose, fructose, maltose, ribose, mannose, and
xylose, disaccharides such as trehalose, sucrose, myoinositol,

anthocyanin. Suitable cryoprotectants include, but are not
limited to, monosaccharides such as glucose, fructose, mal
tose, ribose, mannose, and xylose, disaccharides such as tre

phosphorylated inositols, and glycerol, polysaccharides such

halose, sucrose, myoinositol, phosphorylated inositols, and

protectants include, but are not limited to, monosaccharides

as hydroxyethyl starch and other starches, dextran, and hyalu
ronic acid, and polymers such as polyvinylpyrrolidone, algi

35

glycerol, polysaccharides such as hydroxyethyl starch and
40

other starches, dextran, and hyaluronic acid, and polymers

nates, carrageenan, cyclodextrins, polyvinyl alcohol, cellu

such as polyvinylpyrrolidone, alginates, carrageenan, cyclo

lose-derivatives such as carboxymethyl cellulose, methyl

dextrins, polyvinyl alcohol, cellulose-derivatives such as car

cellulose, hydroxypropyl cellulose, hydroxypropylmethyl

boxymethyl cellulose, methyl cellulose, hydroxypropyl cel
lulose, hydroxypropylmethyl cellulose, xanthan gum, and

cellulose, xanthan gum, and chitosan. It will be appreciated
that the ?nal pH of the extract will depend on both the con

45

centration of the berry extract in the solvent composition and
on the speci?c solvent composition used for extraction. The
berry extract so recovered typically comprises at least one
stabilized anthocyanin in an amount effective to provide anti

oxidant and anti-in?ammatory activity. In another embodi

50

ment, the recovered berry extract has a pH of about 3.5. The
stabilized anthocyanin may be a delphinidin, a petunidin, a
cyanidin, a pelargonidin, a peonidin, a malvidin, or any com

bination thereof.
The physically disrupted berries may be exposed to a sol
vent composition comprising an alcohol and at least one acid,
with the acid provided in a suf?cient amount whereby the
solvent composition has a pH of from about 1 to about 3. The
acid may be provided in an amount of from about 0.005% to
about 3% (v/v) of the alcohol. In one embodiment, the acid is
provided in an amount of from about 0.01% to about 2% of

the alcohol (v/v). In yet another embodiment, the acid is
provided from about 0.01% to about 1% of the alcohol (v/v).
Any of a number of alcohols may be suitable for the present
invention, including, but not limited to, lower chain alcohols
such as methanol, ethanol, propanol, butanol, and mixtures
thereof. The acid may be any acid suitable for providing the
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chito san. The berry extract may be derived from a blackberry.
In one embodiment, the berry extract has a pH of from about
1 .0 to about 4.5. In another embodiment, the berry extract has
a pH of about 3.5. The stabilized anthocyanin may be a
delphinidin, a petunidin, a cyanidin, a pelargonidin, a peoni
din, a malvidin, and combinations thereof.
The solvent composition may comprise an alcohol and at
least one acid, wherein the acid is provided in an amount
suf?cient wherein a pH of the solvent composition is from
about 1 to about 3. The acid may be provided in an amount of
from about 0.005% to about 3% (v/v) of the alcohol. The

alcohol may be any suitable alcohol, including but not limited
to lower chain alcohols such as methanol, ethanol, propanol,
butanol, and mixtures thereof. The acid may be any acid
suitable for providing the desired pH of the solvent compo
60
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sition, including, but not limited to, hydrochloric acid, acetic
acid, citric acid, lactic acid, tri?uoroacetic acid, aspartic acid,
glutamic acid, formic acid, phosphoric acid, maleic acid, and
combinations thereof. Optionally, in place of the alcohol a
suitable ketone or a suitable halogenated ole?n may be used,
such as acetone, chloroform, methylene chloride, and mix

tures thereof. As discussed above, the physically disrupted
berries may be dewatered to a water content of up to 20%

US 8,367,126 B2
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(w/v), such as by freeze-drying, either prior to exposing to the
solvent composition, after exposing to the solvent composi

and/or the active ingredient primarily drain into the stomach.
Formulations meeting these criteria include, but are not lim

tion, or both.

ited to, chewing gums, gels, sprays, lozenges, lollipops or
other candies, rapidly dissolving strips, and the like. In one

A variety of formulations for oral and/ or topical adminis
tration are contemplated for the composition of the present

embodiment, the formulation for oral administration is a tab

invention. In one embodiment, a formulation for oral admin

let or hard-gelatin capsule. In another embodiment, the for

istration is provided, comprising the berry extract in an
amount of from about 3% (w/w) to about 90% (w/w). In
another embodiment, a formulation for topical administration
is provided, comprising the berry extract in an amount of from

mulation is coated with a substance to control the rate or

about 1% (w/w) to about 20% (w/w). It will be appreciated by

coated oral formulations. An enteric-coating refers to a coat
ing on an oral dosage form that is meant to cause the oral

location of disintegration, i.e., an enteric-coated or ?lm
coated formulation.

The present invention contemplates providing enteric

the skilled artisan that a large number of topical and oral

dosage form to remain intact in the lower pH of the stomach,
but disintegrate once the dosage form reaches the higher pH
of the intestines including the small intestines, large intes

formulations are known in the art, such as nutritional supple

ments, capsules, enteric-coated capsules, ?lm-coated cap
sules, tablets, enteric-coated tablets, ?lm-coated tablets,
chewing gums, lotions, creams, mucoadhesive gels, vanish
ing lotions, vanishing creams, and the like. Other ways to
apply a composition topically formulations are known,
including but not limited to: sprays, ointments, gels, patches,
and needle-free devices that deliver their contents by diffu
sion, mechanical or gas-driven energy. The making of such
formulations and/or devices is well within the ability of the

tines, colon, or rectum. The most common enteric coatings
are those that remain intact (undissociated) in the low pH of

the stomach, but ionize when the pH is above pH 4-5, pH 5-7,
20

polyvinyl acetate phthalate, hydroxypropylmethyl cellulose
phthalate, cellulose acetate trimellitate, carboxymethyl eth
ylcellulose, and hydroxypropyl methylcellulose acetate suc

skilled artisan, and such formulations and methods are con

templated also by the present invention.
For example, it is known to provide compositions in emul

cinate, and polymethacrylates (methacrylic acid copolymer)
25

sion or microemulsion form, as lotions and/or creams. A
lotion refers to a semi-viscous emulsion that is meant to be
applied to the skin. A cream refers to a more viscous emulsion

that is also meant to be applied to the skin. Lotions and creams
may be of the oil-in-water or water-in-oil type. In one
embodiment of the present invention, lotions and creams of
the oil-in-water type are provided which stabilize a compo

remaining undissociated or stable until a pH 7 environment is
30

but are not limited to, EUDRAGIT-based polymers that are

soluble in intestinal ?uid at a pH greater than 7, pectin, amy

lose, and chitosan-based polymers.
It is also envisioned that a colon or tumor-speci?c ?lm

coating can be used on the oral dosage form that effectively
35

serves to increase the delivered concentration of the compo

sition of the present invention by selective removal of the
coating by an endogenous enzyme present in the target tissue
of the small intestines, large intestines, colon, or rectum.

thermodynamically unstable systems, and usually require the
application of high-torque mechanical mixing or homogeni
zation to produce dispersed droplets in the range of about 0.2
to 25 pm. In contrast, a microemulsion is a stable biphasic

including EUDRAGIT-based polymers. It is also contem
plated to provide ?lm-coated oral formulations. A ?lm-coat
ing typically targets the coated substance to the colon by

reached. Film-coating materials to achieve this goal include,

sition according to the present invention, and/or promote its
penetration into or through the skin layers.
An emulsion refers to a biphasic opaque mixture of two
immiscible liquids stabilized by a surfactant. Emulsions are

or even above pH 7. Common enteric-coating materials
include, but are not limited to, cellulose acetate phthalate,

Alternatively, it is envisioned that tumors in the colon or
40

rectum can be targeted by coating the dosage form with a

ligand speci?c for the tumor cell surface, i.e., without limita

mixture of two immiscible liquids stabilized by a surfactant
and usually a co-surfactant. Microemulsions are thermody

tion an antibody or binding fragment thereof.
A chewing gum is a ?avored composition that is meant to
deliver a ?avor or other substance by chewing. The primary
part of chewing gum is the gum base, which is a non-nutritive

namically stable, isotropically clear, form spontaneously
without excessive mixing, and have dispersed droplets in the

range of about 5 nm to 140 nm. Both microemulsions and 45
emulsions can be made as water-in-oil or oil-in-water sys
substance. The gum base may consist of any one or more of
the following; an elastic ingredient, a resin that acts as a
tems. In a water-in-oil system, the dispersed phase is water
and the continuous phase is oil. In an oil-in-water system, the
binder and softener, a plasticizer, ?llers, a sweetener or ?a

dispersed phase is oil and the continuous phase is water.
Whether water-in-oil or oil-in-water systems will form is
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largely in?uenced by the properties of the surfactant. The use
of surfactants that have hydrophilic-lipophilic balances
(HLB) of about 3-6 tend to promote the formation of water
in-oil microemulsions while those with HLB values of about
8-18 tend to promote the formation of oil-in-water micro
emulsions.

from The Code of Federal Regulations (Title 21, Volume 3,
Subchapter B) lists ingredients that may be used in gums,
including arabinogalactan, natural gum bases including
chicle, chiquibul, crown gum, gutta hang kang, massaranduba
55

Formulations contemplated for oral administration

styrene rubber, isobutylene-isoprene copolymer, para?in,

ited to, nutritional supplements, capsules, enteric-coated cap
60

suspensions. It is envisioned that more novel particle-based
suspensions for oral administration can be produced, such as

emulsions, microemulsions, nanoparticle or microparticle
suspensions. It is also contemplated in this invention that a
formulation for oral administration may be prepared that is
delivered to and retained in the mouth, whereby the contents

balata, massaranduba chocolate, nispero, rosidinha, Venezu
elan chicle, jelutong, leche capsi (sorva) perillo, leche de
vaca, niger gutta, tunu, chilte, natural rubber (smoked sheet
and latex solids), synthetic substances such as butadiene

directly to the gastrointestinal tract include, but are not lim

sules, ?lm-coated capsules, tablets, enteric-coated tablets,
?lm-coated tablets, chewing gums, caplets, solutions, and

voring agent, and an antioxidant. As an example, Subpart G
titled “Gum, Chewing Gum Bases and Related Substances”

65

petroleum wax, petroleum wax synthetic, polyethylene, poly
isobutylene, and polyvinyl acetate, plasticizing materials
including glycerol ester of partially dimerized rosin, glycerol
ester of partially hydrogenated gum or wood rosin, glycerol
ester of polymerized rosin, glycerol ester of gum rosin, glyc
erol ester of tall oil ro sin, glycerol ester of wood rosin, lanolin,

methyl ester of rosin partially hydrogenated, pentaerythritol
ester of partially hydrogenated gum or wood rosin, rice bran

US 8,367,126 B2
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wax, stearic acid, sodium and potassium stearates, synthetic
and natural terpene resins, antioxidants including butylated

The cancer may be a skin cancer, an oral cancer, a cancer of

the eye, a cancer of a mucosal surface such as the vagina, the

hydroxyanisole, butylated hydroxytoluene, propyl gallate,

nose, and the rectum, and combinations thereof. As described

carrageenan, carrageenan with polysorbate 80, salts of carra
geenan, furcelleran, salts of furcelleran, gellan gum, and xan
than gum. Of course, compositions in addition to those of the

above, the composition may be formulated for administration
by at least one of orally, topically, and by injection.
In yet still another aspect, the present invention provides
compositions for treating in?ammation, oxidative damage, or

present invention may be included as is known in the art to

provide desirable attributes for the gum, such as enjoyment

cancer in a mammal in need thereof, comprising a therapeu
tically effective amount of a composition as described above

(taste, mouth-feel, and the like), breath freshening, dental
care, and oral care.

in a pharmaceutically acceptable vehicle. The composition

Still further, the compositions of the present invention may
be provided along with a mucoadhesive polymer excipient,

may further comprise at least one additional anti-cancer
agent, at least one additional anti-oxidant, at least one addi

for direct delivery to a mucosal surface and also for transmu

tional anti-in?ammatory agent, and combinations thereof.
The compositions may be formulated for administration by at
least one of orally, topically, and by injection as described

cosal delivery into systemic circulation. Brie?y, mucoadhe
sive polymer excipient refers to a polymer that has the ability
to adhere to mucin. Typically, for the compositions of the
present invention a mucoadhesive acidic polymer excipient is
used, which when dissolved or suspended in water results in
an acidic pH. In one embodiment, the mucoadhesive polymer
will provide a polymer solution or suspension having a pH of
from about 1 to about 4.5. The polymer may be non-ionic or

above.

The examples provided herein are presented in support of
20

and to further illustrate the invention as described above and
in the accompanying drawings, but are not to be considered as
limited thereto. Citations of literature herein are incorporated

anionic. Mucoadhesive polymer excipients will typically be

into this disclosure by reference in their entirety unless oth

selected which also control the rate of release of the active

erwise indicated. Generally, 2,2-Azinobis(3-ethylbenzothia
zoline-6-sulfonicacid)diammonium salt (ABTS), Trolox

ingredient from the gel by providing a controlled rate of

polymer rehydration. The mucoadhesive polymer excipient

25

may be present in the dosage form in one embodiment in a

weight percentage between 5-50%. In another embodiment,
the excipient is present in a weight percentage between
5-20%. In yet another embodiment, the excipient is present in
a weight percentage between 5-10%. As non-limiting
examples, the mucoadhesive polymer excipient may be

ethyl-thiazol-2-yl)-2,5-diphenyl
tetrazolium
bromide
(MTT), Folin and Ciocalteau phenol reagent and gallic acid

(98% purity) were purchased from Sigma (St. Louis, Mo.).
30

lulose, cellulose or derivatives thereof, or alginate.
Of course, additional substances may be included in the
formulations of the present invention to provide additional
desired properties, such as sweeteners or preservatives.
Sweeteners may be of natural original or synthetic, and may

lutei200 proof) was purchased from AAPER Alcohol and

Chemical Co. (Shelbyville, Ky.). HPLC grade acetonitrile
was purchased from Fisher Scienti?c (Fair Lawn, N.J.).
35

EXAMPLE 1

A blackberry puree was prepared by pulping whole black
40

include, but are not limited to, fructose, glucose, glycerol,

lactitol, maltitol, maltose, sorbitol, xylitol, saccharin, aspar
tame, cyclamate, sucralose, or acesu?ame potassium, or mix
45

Blackberries were picked from the vine and placed in con
The berries were not washed in order to prevent deterioration
50

methyl paraben, propyl paraben, or mixtures thereof.
Still yet further, the present invention provides a method of
treating in?ammation, oxidative damage, or cancer, compris
ing administering to a mammal such as a human in need

kept with the fruit pulp rather than separated.
tainers for transporting to the picking station for inspection.

benzyl alcohol, benzethonium chloride, butyl paraben, cet

rimide, chlorobutanol, cresol, ethyl paraben, phenol, phe
noxyethanol, propylene glycol, sodium benzoate, thimersol,

berries. For purposes of this disclosure, the term pulping
refers to the process of removing the seeds and skin from
whole fruit. However, it will be understood by those skilled in
the art that the skin and seeds also contain many biologically
useful substances and so it is envisioned that the skin and
seeds may be retained for later use, or alternatively may be

tures thereof. Preservatives are natural or synthetic chemicals

that are added to hinder spoilage, whether caused by micro
bial growth, or unwanted chemical changes such as, but not
limited to, hydrolysis or oxidation. Suitable preservatives
may include, but are not limited to, benzoic acid, sorbic acid,

Hydrogen chloride ~l .25 M in ethanol was purchased from

Fluka (St. Gallen, Switzerland). USP grade Ethanol (Abso

selected from one or more of the following polymers: poly

acrylic acid, crosslinked polyacrylic acid, polyvinyl pyrroli
done, cross-linked polyvinyl pyrrolidone, polymethacrylic
acid, polymethacrylic-acid co-polymers, carboxymethyl cel

(6-hydroxy-2,5,7,8-tetramethychroman-2-carboxylic acid),
potassium persulfate, formic acid (ACS, >96%), 3-(4,5-dim

55

of the whole berry by surface water. The seeds and skin of the
berries were removed using a Langsenkamp type 161 Colos
sal Pulper having two agitator arms with brushes with a
stainless steel chamber, and stainless steel catch pan with two
outlets (one threaded and one with a sanitary ?tting) with a
lO-horse power, 3 phase, 60 cycle, 230/460 volt meter. Whole

blackberries were passed through the Lagsenkamp Pulper at

thereof an effective amount of a composition as described

a rate of 50-75 gallons/minute to produce a homogenous

above. The in?ammation may be associated with cancer,

blackberry puree free of skin and seeds. The blackberry puree

in?ammatory bowel disease, gastroesophageal re?ux dis
ease, diarrhea, radiation-induced enteritis, chemotherapy-in
duced enteritis, Crohn’s disease, irritable bowel syndrome,
diverticulitis, ulcer, colitis, viral infection, bacterial infection,

was stored frozen at —200 C.
60

parasitic infection, and combinations thereof. The in?amma
tion may be partially mediated by the release in the body of
the mammal of at least one cytokine including, but not limited
to, an interleukin such as IL- 1, IL-6, or IL- 1 2, or TNF-(x, and
IFN-(x. The oxidative damage may be mediated at least par
tially by release of a free radical in the body of the mammal.

EXAMPLE 2

A VirTis Model AD2 Lyophilizer was used to freeze-dry a

65

blackberry puree, prepared as described in Example 1, to
produce a free-?owing powder. The cycle used a freezer
temperature of —400 C., a condenser temperature of —50° C.,
and vacuum of 200 mTorr. Approximately 10 g of blackberry
puree in a glass lyophilization vial was freeze-dried. The

US 8,367,126 B2
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following drying steps were used to prepare a purple cake of

water sorption. Three vials were held at 25° C. and three vials
were held at 4° C. The percentage weight increase over time
due to water sorption was recorded for a period of 45 hr. As

freeze-dried blackberry puree:
TABLE 1

shown in FIG. 1, blackberry powder stored at 25° C. increased
in weight by up to 10% by 30 hr, and then reached a plateau.
In contrast, blackberry powder stored at 4° C. increased in
weight by less than 1 .7% and reached a plateau after only 5 hr.

Example Freeze—Drying Cycle for Blackberry Puree
to Produce Active Pharmaceutical Powder

Drying

Temp

Time

Vacuum

Steps

(° C.)

(min)

(mTorr)

1
2
3
4

—35
—30
—25
—20

10
5
5
1200

200
200
200
200

5
6

—15
—10

840
10

200
200

7
8
9
10
11
12

—5
0
5
10
15
20

10
10
120
3 00
10
180

200
200
200
200
200
200

Post Heating

25

90

200

EXAMPLE 5

Two different blackberry extracts were obtained by sub

jecting 2.5 g blackberry powder (Example 2) three times with
either; sample A) 20 mL of ethanol/0.1% HCl or, sample B)
20 mL of ethanol/0.01% HCl under sonication. The three
samples for each extraction condition were collected and
centrifuged for 10 min at 12,000 g. The supernatant was then
?ltered to collect dark red solution. Ethanol was then removed
at 400 C. using a rotary evaporator to obtain a dark red,
viscous liquid. Ten (10) mL of water was added to sample A
20

to produce a dark-red suspension having a pH of 1.2. Ten (10)
mL of water was added to sample B to produce a dark-red

The freeze-dried blackberry puree was collected from the

suspension having a pH of 1.9. Both sample A and sample B

glass lyophilization vial and milled using a mortar and pestle
to produce a free-?owing reddish-purple powder.

were centrifuged for 10 min at 12,000 g and a ?nal dark-red
solution referred to berry extracts. As will be discussed in

EXAMPLE 3

25

greater detail below, the resulting compositions are enriched
for stabilized anthocyanins.

A Hull lyophilizer was employed to create a second

EXAMPLE 6

embodiment of a dry powder of the blackberry puree. A

partially frozen blackberry puree (Example 1) (5204 g) was
placed into the lyophilizer on metal pans in large chunks. The
following lyophilization cycle shown in Table 2 was used to

30

An aliquot of freeze-dried blackberry powder (2.5 g) pre
pared as described in Example 2 was treated under sonication

for 30 min with 60 mL of ethanol containing 0.01% HCl. The
supematants were collected after ?ltration and dried by rotary

dry the blackberry puree:
TABLE 2
35

Lyophilization Cycle Used to Produce
Freeze—Dried Blackberry Powder

Steps
. Freeze to —40° C.

. Raise temp to —35° C.

40

. Once at —35° C., hold for 3 hr
Set vacuum to less 150 microns

The blackberry extract was characterized for: i) mono

. Once at —10° C., hold for 3 hr

dant Capacity (TEAC) Assay, and iv) anthocyanin composi
45

. Once at 0° C., hold for 3 hr
. Raise Temp to 5° C.
. Once at 5° C., hold for 2.5 hr
. Raise temp to 10° C.

. Once at 20° C., hold for 2.5 hr

tion. Results of characterization for i, ii, and iii are shown in
Table 3 below. It is important to note that the values for these
several parameters are likely in?uenced by the extraction

ef?ciency of the berry extract. Thus, it may be appreciated by

. Once at 10° C., hold for 2.4 hr
. Raise temp to 20° C.

gram of blackberry powder.
meric anthocyanins and polymeric color measurement, ii)
Total Phenolic Measurement, iii) Trolox Equivalent Antioxi

. Raise temp to —10° C.

. Maintain vacuum of less than 150 microns
. Raise temp to 0° C.

evaporation at 400 C. The dried extract was dissolved in 10
mL of deionized water and ?ltered through a 1.0 pm nylon
syringe ?lter. The blackberry extract had a pH of 1.9. The
extract was either frozen at —200 C., or lyophilized to produce
a dried blackberry extract (DBE) and then stored as a powder
at —200 C. The average yield ofDBE was 470.44:9.27 mg per

50

. Break vacuum

those skilled in the art that a different extraction protocol may
result in a berry extract that has different composition and
features.
TABLE 3

The resulting blackberry powder weighed 559 g and was
10.7% w/w of the initial blackberry puree that was lyo

Composition and Characterization
of Dried Blackberry Extract (DBE)

philized. Next, 100 g of the freeze-dried blackberry powder
was treated under sonication with 500 mL ethanol containing
0.01% HCl for 30 min to produce a blackberry extract having
a pH in the range of 1.9-2.0. The suspension was ?ltered and
the supernatant was collected in a ?ask. The supernatant was

dried at 40° C. for 7 hr using a rotary evaporator. The recov
ered blackberry extract weighed 19.12 g or 19.12% w/w of

the original 100 g dried blackberry powder.
EXAMPLE 4

Five hundred milligram portions of blackberry powder
prepared as described in Example 2 were evaluated for rate of

Total

Total

TACC

Anthocyanins" Phenolicsl7 Polymeric
(mgg DBE) (mgg DBE) color (%)
60

Blackberry
extract

6.80 z 0.31

17.32 1 0.74

2.2 11.0

(pM TEd/
g DBE)
66.98 1 1.27

(11 = 3)
“Total anthocyanins were expressed as cyanidin-3-glucoside equivalent.
bTotal phenolics were expressed as gallic acid equivalent.
65 CTAC: total antioxidant capacity measured by Trolox-equivalent antioxidant capacity assay.

dTE: Trolox equivalent.
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i) Monomeric Anthocyanins and Polymeric Color Mea

100% acetonitrile (B). The elution conditions were as fol

surement. Monomeric anthocyanin content was determined

lows: 0-45 min, linear gradient from 1 to 16% B (v/v); 46-50
min, linear gradient from 16% to 100% B; 51-60 min, 100%
B; post-time 5 min with 1% B; ?ow rate 1 mL/min. The

by the pH-differential method of Giusti and Wrolstad (2001).
Brie?y, samples were diluted 1:100 v/v in a 25 mM potassium
chloride buffer (pH 1.0) and a 0.4 M sodium acetate buffer
(pH 4.5), then read against a blank at 510 nm and 700 nm with
1 cm path length disposable cuvettes. Total anthocyanin con
tent was calculated using the equations below.
A:(A510_A700) PH 1-0_(A510_A700) PH 4-5

UV-visible detection wavelength was 524 nm and the inj ec
tion volume was 50 uL of the berry extract. The MS instru

ment was operated at the following settings: ESP+ mode;
capillary voltage, 3.0 kV; cone voltage, 35 V; desolvation
temperature, 300° C.; source temperature, 100° C.; scan
range, 100-1000 m/Z. The HPLC pro?le of the berry extract

Equation (1)

showed six major peaks as identi?ed as 1-6 (FIG. 2). Peak

Equation (2)

identi?cation was carried out based on the molecular weight

Where:

and structural information obtained from their MS spectra, in
addition to their retention times from HPLC-UV-vis spectra.
It is notable that other small peaks as shown in the chro
matogram in FIG. 2 were not identi?able by MS and their

A is the absorbance of the diluted anthocyanin sample;
C is the anthocyanin concentration (mg/L);
MW is the molecular weight (449.2 for cyanidin-3-glu

coside);

identity remains unknown. Cyanidin-3-glucoside (peak 1)

DF is the dilution factor; and
e is the molar absorptivity (26900 for cyanidin-3-gluco

was the main component (71.0%) in the berry extract with the

Color density and polymeric color were calculated using

respective parent and daughter ion pairs (m/Z 449/287). The
other three major peaks (peak 4, 12.4%; peak 5, 3.5%; peak 6,

absorption at 420, 510 and 700 nm with and without bisul?te
treatment. The percentage of polymeric color was determined

593/287 which were identi?ed as cyanidin-3-xyloside, cya

side).

by the ratio of polymerized color to color density.
ii) Total Phenolic Measurement. Total phenolic content in

20

11.6%) revealed the m/Z values of 419/287, 535/287 and

25

the berry extract was estimated based on the method of

Singleton and Rossi (1965) using gallic acid as a standard.
Twenty (20) uL of diluted samples was added to 1.58 mL
distilled water along with 100 uL of a 2N Forlin-Ciocalteu
phenol reagent. All solutions were mixed thoroughly and then

nidin-3 -malonylglucoside and cyanidin-3-dioxalylglucoside
respectively, in accordance with data previously reported by
StintZing et al. (2002). Cyanidin-3-arabinoside (peak 2) was
also identi?ed, and was in agreement of the initial report by

Dugo et al. (2001) using blackberry extracts. Another small

peak (peak 3), with the respective parent and daughter ion
30

pairs (m/Z 435/303), was detected in the blackberry extract

allowed to sit at room temperature for 1 min. Three hundred

and is being reported for the ?rst time. Based on its retention

(300) pl saturated sodium carbonate solution (200 g/L) was

time, this compound has been tentatively identi?ed as del

then added to each sample. The absorbance was measured at
765 nm with a Beckman UV-visible spectrophotometer after
incubation for 2 hr at room temperature. Total phenolics were
determined based on the standard curve generated with 0.2,

phinidin-3-xyloside.

0.4, 0.6, 0.8, and 1.0 mg/mL of gallic acid.

An HPLC assay was used to quantify the anthocyanin

iii) Trolox Equivalent Antioxidant Capacity (TEAC)
Assay. TEAC assay for the berry extract was carried out using
a Beckman DU640B spectrophotometer following proce
dures described by Re et al., (1999). ABTS'+ was produced

EXAMPLE 7

35

content and stability in berry samples. The standard chro
matogram gave two peaks corresponding to: peak 1:cyani
40

din-3 -glucoside and cyanidin-3-sambubioside; and peak
2:cyanidin-3-rutinoside and cyanidin-3-(2G-xylosylrutino

by reacting 7 mM ABTS with 2.5 mM potassium persulfate

side). A standard curve showed excellent linearity over a

for 16 h in the dark at room temperature. The ABTS'+ solu
tion was diluted with ethanol to an absorbance of 0.70 (10.02)

range of from 50 to 2000 ug/mL with R2>0.999 for both peak

at 734 nm and equilibrated at 30° C. Twenty (20) ul of the
berry extract samples were added to 980 nl of diluted

1 and peak 2. FIG. 3A depicts the stability of peak 1 and peak
45

2 after one day at 4° C. in formulations made from pH 4.5 to

7.5. FIG. 3B depicts the stability of peak 1 and peak 2 after 28

ABTS'+ solution, such that each ?nal sample produced

days at 4° C. in formulations made at pH 3.5 or pH 4.0.

between 20-80% inhibition of the blank absorbance. The
absorbance readings were taken continuously every 6 s for 6

were formulated at a ?nal concentration of 10% w/w in mix

min at 734 nm at 30° C. Trolox standards in ethanol with ?nal

Freeze-dried berries (prepared as described in Example 2)
50

concentration ranging from 0 to 16.8 uM were prepared and
assayed under the same conditions. The total antioxidant
capacity of the berry extract was calculated and expressed as

umol Trolox equivalent (TE) per gram of dried blackberry
extract (DBE). The total antioxidant capacity (TAC) of the

tures having different pHs from pH 7.5, 6.5, 5.5, 4.5, 4.0, and
3.5 and stored at 4° C. for 1 day. As shown in FIG. 3A, peak

1 andpeak 2 showed much greater stability at lowerpH values
55

after 1 day. The results of a second study are shown in FIG.
3B. In this study, the berries were formulated at pH 3 .5 and 4.
Formulation of the berries at pH 3.5 provided excellent sta

berry extract was determined using an improved TEAC assay

bility for peak 1 (96.0:0.8%) and peak 2 (100.2:0.4%) over

(Re et al., 1999), which assessed the capacity ofa compound

1 month at 4° C.

or sample to scavenge ABTS'+ in terms of Trolox equivalent.
The average TAC value of the berry extract was 669811.27

mmol TE per gram of DBE (see Table 3).

EXAMPLE 8
60

iv) Anthocyanin Composition. HPLC-UV-MS analysis

Blackberry extract (19.12 g, see Example 3) was dissolved

was performed using a X-BridgeTM C18 column (250
mm><4.6 mm, 5 pm) (Waters) equipped with an X-BridgeTM
C18 guard column with a Waters 2690 separation module
equipped with a 996 photodiode array detector, and coupled

in 500 mL water to produce a stock solution of 38.24 mg

extract/mL. Total anthocyanin content of the 19.12 g black
berry extract was found to be 181.3 mg/L by the pH differ

on-line with a Waters Micromass ZMD 4000 Mass Spectrom

ential method. This corresponded to a total anthocyanin con
tent of 90.6 mg from the 19.12 g ofblackberry extract (0.5%

eter. The mobile phase consisted of 10% formic acid (A) and

w/w anthocyanins).

65
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76.48 mg extract was mixed with 8 mL of 10% mannitol and

glucoside over 90 days when the blackberry extract solution
was stored at 250 C., indicating that the anthocyanin was less

lyophilized to produce a dried berry extract with mannitol.

stable as the temperature increased.

The ?nal mannitol concentration in the solution was 8% and

To further con?rm the stability of dried blackberry extracts
stored under various conditions and at various temperatures,

Two (2) mL of the blackberry extract, corresponding to

the ?nal pH ranged from 2.5 to 2.6. In addition, blackberry
extract alone (without mannitol) was lyophilized to produce a
dried berry extract. The lyophilization procedure for both the
dried berry extract with mannitol and dried berry extract is

freeze-dried blackberry powder was stored at —200 C. as a

control, dried berry extract was stored at 4° C. and 250 C., and
dried berry extract with mannitol stored at 4° C. and 250 C.

The stability time points collected were at time 0, 2 weeks, 4
weeks, and 8 weeks.

shown in Table 4.

Sample quantitation was performed by comparing the area
TABLE 4

of each stability data point to the area for the Time 0 point for

Lyophilization Cycle Used to Prepare Dried Berry

extract, or dried extract with mannitol). Equation 3 was used

each type of sample (freeze-dried blackberry powder, dried

Extract and Dried Berry Extract with Mannitol

to calculate the concentration (mg/mL) of the sample using
the actual weight of sample.

Steps
. Freeze to —40° C.

. Raise temp to —35° C.

. Once at —35° C., hold for 3 hr

Actual Weight of Sample

,

. Set vacuum to less 150 microns

C = Sample concentration

. Raise temp to —10° C.

=

Equation (3)

Volume of Dilution

20

. Once at —10° C., hold for 15 hr
. Maintain vacuum of less than 150 microns
. Raise temp to 0° C.

The percent of each sample peak area relative to the peak area
at the Time 0 point was calculated using Equation 4.

. Once at 0° C., hold for 3 hr
. Raise Temp to 5° C.
. Once at 5° C., hold for 10 hr

25

. Raise temp to 5° C.

. Once at 10° C., hold for 3.4 hr

% Peak Area =

. Raise temp to 20° C.

Peak Area at Timepoint

CTimeO

Peak Area at Time 0

CTimepoint

X 100

Equation (4)

. Once at 20° C., hold for 2.5 hr
. Break vacuum

As shown in FIG. 5A, the Cn-3-glucoside in the freeze
To observe the stability of the blackberry extract in solution
alone, and in the presence of 8% mannitol, the extract was
stored at 4° C. and 25° C. for 1 month. As shown in Table 5
below, at both temperatures, the presence of 8% mannitol in

30

dried blackberry powder stored at —200 C. was stable for at

least eight weeks. Likewise, Cn-3-glucoside remained stable
in both the dried blackberry extract and the dried blackberry
extract with mannitol stored for 8 weeks at 4° C. Cn-3

glucoside was continuously lost in the dried blackberry

solution was able to stabilize the retention of four different

extract over 8 week storage at 250 C. After 8 weeks, the

anthocyanins in solution designated by Peak 1 (Cn-3-gluco
side), Peak 2 (Cn-3-arabinoside), Peak 3 (Cn-3-xyloside),
and Peak 4 (Cn-3 -malonyl-glucoside).

retained Cn-3 -glucoside was only about 65% of the original.
In contract, Cn-3-glucoside remained stable in the dried

TABLE 5

effect on the dried blackberry extract and in particular Cn-3
glucoside. As shown in FIG. 5B, this effect was also observed
for at least three other anthocyanins. FIG. 5B shows the

blackberry extract with mannitol stored for 8 weeks at 250 C.

Surprisingly, this suggested that mannitol had a stabilizing
40

Retention of Anthocyanins in Berry Extract Solution and
Berrv Extract with 8% Mannitol Solution Over 1 Month
Peak 1

Peak 2

Peak 3

stability of Cn-3-glucoside, Cn-3-arabinoside, Cn-3-xylo
side, and Cn-3-malonyl-glucoside over 8 weeks at 250 C.

Peak 4

stored as either a dried blackberry extract or dried blackberry

extract lyophilized in 8% mannitol.

% Retention of Anthocyanin Peak Area after
Storage at 4° C. for 1 month
Berry Extract

89.7 r 0.3

86.2 r 13.2

90.7 r 3.1

88.0 r 6.7

109.5 14.9

115.6 1 10.7

EXAMPLE 9

in Solution
Berry Extract

106.0 1 1.0

138.0 1 5.9

with Mannitol

A blackberry extract was obtained by extracting 2.5 g
50

% Retention of Anthocyanin Peak Area after
Storage at 25° C. for 1 month
Berry Extract

79.2 r 0.2

75.5 r 10.8

101.9 1 0.6

96.7 r 3.4

81.3 r 2.4

three extracts were collected and the ethanol was removed by
rotoevaporation. Ten (10) mL of water was then used to

69.6 r 3.4

rehydrate the reddish purple extract. One (1) mL of the black

in Solution
Berry Extract

102.0 1 4.6

77.2 r 24.3

blackberry powder (prepared as described in Example 2)
three times with ethanol/0.01% HCl (see Example 4). The

55

with Mannitol

berry extract was then added to 4 mL of mannitol at a con

centration of 10%, 5%, 2%, 1%, or 0%. The blackberry
extract/mannitol samples were then lyophilized as described

To observe the stability of blackberry extract in solution
stored at four different temperatures or conditions, blackberry
extract solution was stored frozen at —800 C. as a control, at 4° 60

C., at 250 C. in the dark, and at 250 C. with light for 90 days.
As shown in FIG. 4, the concentration of cyanidin-3-gluco
side remained unchanged over 90 days when the blackberry
extract solution was frozen at —800 C. When the blackberry

in Example 2. A pink free-?owing powder was only obtained
with ?nal mannitol concentration of >8%. The pH of the
blackberry extract/mannitol mixture was in the range of pH
2.5 to 2.6. Freeze-drying of the blackberry extract in ?nal
mannitol concentrations less than 2% resulted in a sticky

gelatin-like product.
EXAMPLE 10

extract solution was stored at 4° C. over 90 days, there was 65

about a 10% loss in the concentration of cyanidin-3-gluco
side. In contrast, there was substantial loss of cyanidin-3

A vanishing lotion base having the composition presented
in Table 6 was prepared by heating a water phase to 70° C. An

